Corrigendum to 'B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis' [J Hepatol (2022) doi: 10.1016/j.jhepr.2022.100460]
- PMID: 40524698
- PMCID: PMC12167470
- DOI: 10.1016/j.jhepr.2025.101447
Corrigendum to 'B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis' [J Hepatol (2022) doi: 10.1016/j.jhepr.2022.100460]
Abstract
[This corrects the article DOI: 10.1016/j.jhepr.2022.100460.].
© 2025 The Author(s).
Erratum for
-
B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis.JHEP Rep. 2022 Feb 22;4(5):100460. doi: 10.1016/j.jhepr.2022.100460. eCollection 2022 May. JHEP Rep. 2022. PMID: 35368991 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
